Accumetrics

3985 Sorrento Valley Blvd
San Diego
CA
92121
USA
Phone: 
888-919-9300
Fax: 
858-643-1605
http://www.accumetrics.com
support@accumetrics.com
Product Categories: Taxo=cardiology_products&Taxo=general_cardiology&Taxo=diagnostic_and_interventional_cardiology_daic&Taxo=cardiovascular_surgery&Taxo=hemostasis_management&Taxo=cath_lab&Taxo=ep_lab

Related Articles

Antiplatelet Therapy

Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test
Clinical Utility of Platelet Reactivity Strongly Advocated at ACC.13
Accumetrics Aligned with Medicare’s Hospital Readmissions Reduction Program
Use of Platelet Function Testing — Does it really aid patient management?
Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as Plavix Loses Patent Protection
ADAPT-DES Registry Finds Higher Stent Thrombosis in High Platelet Reactivity Patients
New Guidelines Recommend Platelet Reactivity Testing Before Surgery
New Approaches, Drugs for Antiplatelet Therapy

Pharmaceuticals

Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test
Clinical Utility of Platelet Reactivity Strongly Advocated at ACC.13
Use of Platelet Function Testing — Does it really aid patient management?
Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as Plavix Loses Patent Protection
ADAPT-DES Registry Finds Higher Stent Thrombosis in High Platelet Reactivity Patients
New Approaches, Drugs for Antiplatelet Therapy
Doubling Dose of Clopidogrel Does Not Improve Outcomes Post-PCI
Collaboration Increases Awareness About Antiplatelet Therapy
Accumetrics Reviews Meta-analysis Anti-Platelet Therapy After PCI at TCT

Blood Testing

Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test
Clinical Utility of Platelet Reactivity Strongly Advocated at ACC.13
VerifyNow II System Gains European CE
Accumetrics Aligned with Medicare’s Hospital Readmissions Reduction Program
Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as Plavix Loses Patent Protection
New CE Marked Prognostic Claim for the VerifyNow Test
New Guidelines Recommend Platelet Reactivity Testing Before Surgery
Doubling Dose of Clopidogrel Does Not Improve Outcomes Post-PCI
Collaboration Increases Awareness About Antiplatelet Therapy
Accumetrics Reviews Meta-analysis Anti-Platelet Therapy After PCI at TCT
Accumetrics Features VerifyNow System at TCT 2008 Conference
VerifyNow Test System Monitors Platlet Function, Therapies

Platelet Function Monitors

Clinical Utility of Platelet Reactivity Strongly Advocated at ACC.13
VerifyNow II System Gains European CE
Use of Platelet Function Testing — Does it really aid patient management?
New CE Marked Prognostic Claim for the VerifyNow Test
New Guidelines Recommend Platelet Reactivity Testing Before Surgery
Accumetrics Features VerifyNow System at TCT 2008 Conference
VerifyNow Test System Monitors Platlet Function, Therapies

Point of Care Testing

Accumetrics Aligned with Medicare’s Hospital Readmissions Reduction Program
Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as Plavix Loses Patent Protection
New Guidelines Recommend Platelet Reactivity Testing Before Surgery
Doubling Dose of Clopidogrel Does Not Improve Outcomes Post-PCI
Accumetrics Reviews Meta-analysis Anti-Platelet Therapy After PCI at TCT
Accumetrics Features VerifyNow System at TCT 2008 Conference
VerifyNow Test System Monitors Platlet Function, Therapies

Cath Lab

Use of Platelet Function Testing — Does it really aid patient management?
Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as Plavix Loses Patent Protection

Stents

ADAPT-DES Registry Finds Higher Stent Thrombosis in High Platelet Reactivity Patients

Clinical Trial/Study

ADAPT-DES Registry Finds Higher Stent Thrombosis in High Platelet Reactivity Patients
Doubling Dose of Clopidogrel Does Not Improve Outcomes Post-PCI

Cardiac Diagnostics

New CE Marked Prognostic Claim for the VerifyNow Test
Collaboration Increases Awareness About Antiplatelet Therapy
Accumetrics Reviews Meta-analysis Anti-Platelet Therapy After PCI at TCT

Cardiology Products

Accumetrics Features VerifyNow System at TCT 2008 Conference
VerifyNow Test System Monitors Platlet Function, Therapies

General Cardiology

VerifyNow Test System Monitors Platlet Function, Therapies

Mammography Systems

Accumetrics Gets $28.8 Million for GRAVITAS Trial